Benzinga | Nov 15, 2021 06:38PM EST

Biocept Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.50M Beat $16.07M Estimate

Biocept (NASDAQ:BIOC) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 50 percent. This is a 106.98 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $17.50 million which beat the analyst consensus estimate of $16.07 million by 8.90 percent. This is a 165.72 percent increase over sales of $6.59 million the same period last year.